Godavari Biorefineries Q2 Results: Net Loss Increases to ₹75 Crore in Q2
TCS Share Q1 Results
Last Updated: 8th August 2022 - 06:41 pm
- TCS reported 18.5% growth in total sales revenues for the Jun-21 quarter on consolidated basis at Rs45,411cr.
- On a sequential basis, the revenues were higher 3.9% compared to Rs43,705cr in the Mar-21 quarter.
- TCS witnessed growth in all its principal verticals including BFSI, manufacturing, retail, CMT and life sciences.
- EBIT margins at 25.5% contracting 130bps QoQ due to the annual wage hikes and visa costs. Management indicated margins are largely sustainable YoY. Hiring was at an all-time high of 20.4k on the back of 19.4k hires in 4Q, as TCS crossed the 500k headcount mark. Attrition rose by 140bps to 8.6% LTM
- Management is confident of delivering double-digit revenue growth and sustaining margins in FY22, supported by ramp up of deals and broad-based improvement in IT spending.
- Deal wins were strong at US$8.1bn (+16% YoY TTM), with a healthy mix of small and large deals.
Revenues by verticals - FY21
Verticals |
Contribution |
BFSI |
31.70% |
Regional Markets & Others |
19.20% |
Retail |
14.40% |
Lifescience |
9.70% |
Mfg. |
9.60% |
Tech |
8.70% |
Telecom |
6.70% |
Revenues by geographies - FY21
Geographies |
Contribution |
America |
51.40% |
UK/Europe |
31.90% |
APAC |
9.60% |
India |
5.20% |
MEA |
2.00% |
Also Check : Result Expectation of Top IT Companies
About the Company:
With 500,000+ employees and FY21 revenues of US$22.2bn, TCS is India’s largest IT services vendor. Though application services remain the primary services offering, the company has attained credible size in other service offerings such as infrastructure services, BPO and testing services. BFSI continues to be TCS’ most important vertical (30% of revenues). Telecom, manufacturing and retail are the other large verticals. The US continues to be the most important geography; however, the company is increasing its presence in Europe/UK.
Disclaimer: The above report is compiled from information available on the public platforms. These are not buy or sell recommendations.
Trending on 5paisa
03
5paisa Research Team
Discover more of what matters to you.
Corporate Actions Related Articles
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.